- Home
- ROIV vs OTEX Comparison
ROIV vs OTEX Comparison
Compare ROIV & OTEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROIV
- OTEX
- Stock Information
- Founded
- ROIV 2014
- OTEX 1991
- Country
- ROIV United Kingdom
- OTEX Canada
- Employees
- ROIV N/A
- OTEX N/A
- Industry
- ROIV Biotechnology: Pharmaceutical Preparations
- OTEX EDP Services
- Sector
- ROIV Health Care
- OTEX Technology
- Exchange
- ROIV Nasdaq
- OTEX Nasdaq
- Market Cap
- ROIV 8.4B
- OTEX 7.8B
- IPO Year
- ROIV N/A
- OTEX 1998
- Fundamental
- Price
- ROIV $10.68
- OTEX $26.83
- Analyst Decision
- ROIV Strong Buy
- OTEX Hold
- Analyst Count
- ROIV 8
- OTEX 8
- Target Price
- ROIV $17.93
- OTEX $32.71
- AVG Volume (30 Days)
- ROIV 4.0M
- OTEX 815.0K
- Earning Date
- ROIV 02-10-2025
- OTEX 02-06-2025
- Dividend Yield
- ROIV N/A
- OTEX 3.91%
- EPS Growth
- ROIV N/A
- OTEX 421.00
- EPS
- ROIV N/A
- OTEX 2.45
- Revenue
- ROIV $122,585,000.00
- OTEX $5,412,785,000.00
- Revenue This Year
- ROIV $15.98
- OTEX N/A
- Revenue Next Year
- ROIV N/A
- OTEX $2.70
- P/E Ratio
- ROIV N/A
- OTEX $10.95
- Revenue Growth
- ROIV 140.04
- OTEX N/A
- 52 Week Low
- ROIV $9.76
- OTEX $26.81
- 52 Week High
- ROIV $13.06
- OTEX $40.55
- Technical
- Relative Strength Index (RSI)
- ROIV 42.58
- OTEX 36.92
- Support Level
- ROIV $10.33
- OTEX $27.83
- Resistance Level
- ROIV $10.86
- OTEX $28.80
- Average True Range (ATR)
- ROIV 0.27
- OTEX 0.95
- MACD
- ROIV 0.02
- OTEX -0.23
- Stochastic Oscillator
- ROIV 29.96
- OTEX 0.40
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About OTEX Open Text Corporation
Open Text Corp is engaged in the design, development, marketing, and sale of Information Management software and solutions. Its software allows clients to archive, aggregate, retrieve, and search unstructured information (such as documents, e-mail, and presentations). Its platform and services provide secure and scalable solutions for enterprises, SMBs, governments, and consumers around the world. The company's solutions are marketed and delivered on the OpenText Cloud Platform, which is a comprehensive Information Management platform consisting of six business clouds; Content Cloud, Cybersecurity Cloud, Application Automation Cloud, Business Network Cloud, IT Operations Management Cloud, and Analytics Cloud. Geographically, it derives maximum revenue from the United States.